Supplementary Files
Keywords
Chronic use of PPIs
Omeprazole
Intestinal polyposis
Gastric polyposis
Gastroesophageal reflux
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To assess the profile of chronic users and investigate the short, medium and long-term negative impacts on the health of chronic users of proton pump inhibitors (PPIs). Methods: Data collection was transversal, descriptive and observational, with a qualitative and quantitative approach. This is an exploratory and descriptive literature review, carried out in an organized, systematic and ethical manner, with existing data from PubMed and UpToDate databases. Results: The N collected was from 31 PPI users, 21 women and 10 men, with PPI use ranging from 67 days to 15 years. The results were presented through graphs, some corroborating pre-existing studies and others showing divergences with the medical literature. Conclusion: More studies should be performed in order to establish a causal relationship of the long-term effects of the use of proton pump inhibitors in the human body.
References
ABRAHAMI D, et al. Proton pump inhibitors and risk of colorectal cancer. 2022; 71(1): 111-118.
AUERBACH M, et al. Causes and diagnosis of iron deficiency and iron deficiency anemia in adults. Up to Date. 2022.
AUSTIN G. Association of Proton Pump Inhibitor Use with Serum Biomarkers of Inflammation, Insulin Resistance, Cardiovascular Risk, and Renal Function. Journal of Clinical Gastroenterology, 2018; 52(8): 691-695.
CORLETO VD, et al. Proton pump inhibitor therapy and potential long-term harm. Current opinion in endocrinology, diabetes, and obesity, 2014; 21(1): 3-8.
GIFFORD AH. et al. Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis. Pediatric Pulmonology, 2021; 56(7): 2048-2056.
GRAHAM D, TANSEL A. Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency. Clinical Gastroenterology and Hepatology, 2018; 16(6): 800-808.
HAASTRUP P, et al. When does proton pump inhibitor treatment become long term? A scoping review. BMJ Open Gastroenterology, 2021; 8(1).
JAYNES M, KUMAR A. The risks of long-term use of proton pump inhibitors: a critical review. Therapeutic advances in drug safety, 2018;10.
KAHRILAS P. Medical management of gastroesophageal reflux disease in adults. Up To Date, [s. l.], 2022.
KOYYADA A. Long term use of proton pump inhibitors as a risk factor for various adverse manifestations, 2021; 76(1): 13-21.
LAMONT T, Treatment regimens for Helicobacter pylori in adults. Up to Date, 2022.
LAZZERINI PE, et al. Proton Pump Inhibitors and Serum Magnesium Levels in Patients with Torsades de Pointes. Frontiers in pharmacology. 2018; 9: 363.
LEE L, et al. Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome. International Journal of Molecular Sciences, 2019; 20(20): 5128.
LEE L, et al. Overview of colonoscopy in adults. UpToDate. Waltham, MA: UpToDate, 2021.
LI Z, et al. Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: A meta-analysis. Saudi journal of gastroenterology: official journal of the Saudi Gastroenterology Association, 2017;
(4): 222-228.
MOUSA H, HASSAN M. Gastroesophageal Reflux Disease. Pediatric Clinics of North America, 2017; 64(3): 487-505.
QORRAJ-BYTYQI, H et al. Proton Pump Inhibitors Intake and Iron and Vitamin B12 Status: A Prospective Comparative Study with a Follow up of 12 Months. Open access Macedonian journal of medical Sciences, 2018; 6(3): 442-446
VELAZQUEZ-DOHORN M, et al. Análisis de casos y controles de pólipos de glándulas fúndicas e inhibidores de bomba de protones. La perspectiva de un patólogo. Revista de Gastroenterología de México, 2020; 85(1): 42-47.
WANG Y et al. Association Between Proton Pump Inhibitor Use and Risk of Asthma in Children. JAMA pediatrics, 2021; 175(4): 394-403.
WOLFE M, et al. proton pump inhibitors: Overview of use and adverse effects in the treatment of acid related disorders. Up to Date, 2022.
YU A, et al. Hypomagnesemia: Causes of hypomagnesemia. Up to Date, 2022.
YU LY, et al. A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors. Advances in Therapy, 2017;34(5):1070-1086.
YU Z, et al. Neutropenia and Thrombocytopenia Induced by Proton Pump Inhibitors: A Case Report. 2018;5(1):28.
YU A, et al. Hypomagnesemia: Clinical manifestations of magnesium depletion. Up to date, 2022.
THOMSON A, et al. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol. 2010.